TCM Biotech International Corp.(TW:4169)
NT$116.50-4.00 (-3.32%)
TW:4169
TCM Biotech International Corp. Revenue
NT$116.50
At close:-4.00 (-3.32%)
TCM Biotech International Corp. (4169) Revenue
TCM Biotech International Corp. Revenue
TCM Biotech International Corp. had a revenue of 181.09M in the quarter ending Jun 30, 2026, with 4.74%. This bring the company's revenue in the last twelve months to 874.29M, Decreased 15.20%. In the fiscal year ending Dec 31, 2025, TCM Biotech International Corp. had annual revenue of 685.49M with 2.84% growth.
- Revenue (ttm)
- 874.29M
- Revenue Growth
- ―
- P/S Ratio
- 11.57
- Revenue/Employee
- TWD 9,390,288
- Employees
- 73
- Market Cap
- TWD 7.93B
Revenue Chart
TCM Biotech International Corp. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 685.49M | 18.96M | 2.84% |
| Dec 31, 2024 | 666.53M | -303.09M | -31.26% |
| Dec 31, 2023 | 969.62M | 167.20M | 20.84% |
| Dec 31, 2022 | 802.42M | 100.38M | 14.30% |
| Dec 31, 2021 | 702.05M | -35.03M | -4.75% |
| Dec 31, 2020 | 737.08M | 168.45M | 29.62% |
| Dec 31, 2019 | 568.63M | 28.40M | 5.26% |
| Dec 31, 2018 | 540.23M | -292.00K | -0.05% |
| Dec 31, 2017 | 540.52M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.